Literature DB >> 20835704

The local vasoconstriction of infant's skin following instillation of mydriatic eye drops.

Atilla Alpay1, Bahri Ermis, Silay C Ugurbas, Fatih Battal, Haci Murat Sagdik.   

Abstract

BACKGROUND: Systemic absorption of eye drops is known to occur via the nasal mucosa, cornea, and conjunctiva. Diffusion of eye drops through the skin is previously unrecognized. Here, two cases are presented in which we observed skin pallor around the eyes after instillation of phenylephrine 2.5% drops. CASE 1: A 32-week gestational age premature infant had mydriatic eye drops instilled as part of retinopathy of prematurity screening. CASE 2: A term newborn dysmorphic infant underwent fundus examination to rule out ocular pathology. In both cases, discoloration of periorbital skin was observed 45 min following administration of drops.
CONCLUSION: The risks of percutaneous toxicity must always be considered in children, especially in premature neonates, in whom the epidermal permeability barrier is frequently incompetent. Application of smaller drop size or wiping of overflowed drop from the skin may be useful to decrease the risk of systemic side effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20835704     DOI: 10.1007/s00228-010-0890-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Development of an in vitro model for premature neonatal skin: biophysical characterization using transepidermal water loss.

Authors:  N Sekkat; Y N Kalia; R H Guy
Journal:  J Pharm Sci       Date:  2004-12       Impact factor: 3.534

2.  Screening criteria for retinopathy of prematurity in developing countries.

Authors:  Ipek Akman; Utku Demirel; Ozlem Yenice; Hacer Ilerisoy; Haluk Kazokoğlu; Eren Ozek
Journal:  Eur J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 2.597

3.  UK retinopathy of prematurity guideline.

Authors:  A R Wilkinson; L Haines; K Head; A R Fielder
Journal:  Eye (Lond)       Date:  2008-10-03       Impact factor: 3.775

4.  Second place winner. Absorption of topical ophthalmic medications presenting as lethargy and apnea in an infant.

Authors:  Kenneth T Kwon; A Antoine Kazzi
Journal:  J Emerg Med       Date:  2002-11       Impact factor: 1.484

5.  The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants.

Authors:  O Elibol; T Alçelik; N Yüksel; Y Caglar
Journal:  Acta Ophthalmol Scand       Date:  1997-04

6.  Acute gastric dilatation complicating the use of mydriatics in a preterm newborn.

Authors:  S U Sarici; M Yurdakök; S Unal
Journal:  Pediatr Radiol       Date:  2001-08

7.  Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides.

Authors:  Carmen Chew; Ropilah Abdul Rahman; Suraiya M Shafie; Zainal Mohamad
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2005 May-Jun       Impact factor: 1.402

8.  Retinopathy of prematurity in practice. I: screening for threshold disease.

Authors:  R Brennan; L Gnanaraj; D G Cottrell
Journal:  Eye (Lond)       Date:  2003-03       Impact factor: 3.775

9.  Development of skin barrier function in premature infants.

Authors:  Y N Kalia; L B Nonato; C H Lund; R H Guy
Journal:  J Invest Dermatol       Date:  1998-08       Impact factor: 8.551

10.  Diode laser treatment for retinopathy of prematurity: structural and functional outcome.

Authors:  C S Ling; B W Fleck; E Wright; C Anderson; I Laing
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

View more
  5 in total

1.  Systemic side effects of locally used oxymetazoline.

Authors:  Recep Dokuyucu; Hasan Gokce; Mustafa Sahan; Fatih Sefil; Zeynel Abidin Tas; Okan Tutuk; Atakan Ozturk; Cemil Tumer; Cengiz Cevik
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Systematic review of mydriatics used for screening of retinopathy in premature infants.

Authors:  Lisa Jean Kremer; David M Reith; Natalie Medlicott; Roland Broadbent
Journal:  BMJ Paediatr Open       Date:  2019-05-09

3.  Efficiency and safety of phenylephrine and tropicamide used in premature retinopathy: a prospective observational study.

Authors:  Atilla Alpay; Sılay Canturk Ugurbas; Cumhur Aydemir
Journal:  BMC Pediatr       Date:  2019-11-06       Impact factor: 2.125

4.  Direct and crossover effects of Phenylephrine and Cyclopentolate on foveal avascular zone and vessel density of macular capillary plexuses: an optical coherence tomography angiography study.

Authors:  Yasin Şakir Göker; Hasan Kızıltoprak; Kemal Tekin; Esat Yetkin; Mustafa Salih Karatepe; Kübra Özdemir; Gokhan Demir
Journal:  Rom J Ophthalmol       Date:  2020 Apr-Jun

5.  Adverse Cardiovascular Effects of Phenylephrine Eye Drops Combined With Intravenous Atropine.

Authors:  Qingyu Li; Jianxin Pang; Yang Deng; Shaochong Zhang; Yong Wang; Yang Gao; Xiaoyong Yuan; Yantao Wei; Hongbin Zhang; Junlian Tan; Wei Chi; Wenjun Guo
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.